{"id":749982,"date":"2023-04-21T08:03:48","date_gmt":"2023-04-21T12:03:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/"},"modified":"2023-04-21T08:03:48","modified_gmt":"2023-04-21T12:03:48","slug":"solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/","title":{"rendered":"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CHARLESTOWN, Mass., April  21, 2023  (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Solid management will participate in a fireside chat at Chardan\u2019s 7<sup>th<\/sup> Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 24, 2023 at 2:00 PM ET.<\/p>\n<p align=\"left\">A live webcast of the fireside chat will be available on the Events page of the Investors section of the Company website or by clicking <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gUuEF5u4TRxRhVZvjTQxuAntT76S4YMqQEzkVlpCy69733DEhW3F1TUjhdESLUftRd15P95zYaFQLkhMvC89zZJm9g6OgdTUjarCgnwrAaOhcJnjEBdCemkap4hqfVKkIbSuHNdVkw6Ozg2S9DcuA9DJ3be3ipF1y_qj4AsxxfR_vTs-doXMwOQ8dfQDvsQJ\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. A replay will be available on the Company\u2019s website following the event.<\/p>\n<p align=\"left\">Institutional investors interested in meeting with management during the conference may reach out to their Chardan representative.<\/p>\n<p align=\"left\">\n        <strong>About Solid Biosciences<br \/><\/strong>Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs, including SGT-003, a differentiated gene transfer candidate for the treatment of Duchenne, AVB-202-TT, a gene transfer candidate for the treatment of Friedreich\u2019s Ataxia, AVB-401 for BAG3 mediated dilated cardiomyopathy, and additional assets for the treatment of undisclosed cardiac diseases. Solid aims to be the center of excellence, bringing together those with expertise in science, technology, disease management and care. Patient-focused and founded by those directly impacted by Duchenne, Solid\u2019s mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ACzhc_2lde99ejF7qm48wtJ3BPYrXlnHUG7YW6nJVkpVikznu5bi6wsMCyNZA_Ddb_hprm-Cqgdn0dpv0mbtOg==\" rel=\"nofollow noopener\" target=\"_blank\">www.solidbio.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Solid Biosciences Investor Contact<\/strong>:<br \/>David Carey<br \/>FINN Partners<br \/>212-867-1768<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MU381YGPIJBRwWUPbNbky7PeY74gTGnOKIZkbJZ-gIUltT3MkudiLVE4kOFr3UwMCsknAzLr8ax4KK-AJUCFl4PihIFO5JJE0JlmJmV-wVMzEWOIEFwSkIM70DBGNb1y\" rel=\"nofollow noopener\" target=\"_blank\">David.Carey@finnpartners.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Solid Biosciences Media Contact<\/strong>:<br \/>Tim Palmer<br \/>Associate Director, Corporate Communications <br \/>607-760-4223<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PUKoyz4SYVvWig3RYQChntMjrHDqnVWNtQ8Cv2RZcHpkmJGemvS3ughiAbMqfOiNFYpxwa1SlWzujP9omT5XQA==\" rel=\"nofollow noopener\" target=\"_blank\">Tim@solidbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODY3ODM2NDctYTkzZS00ZGQ5LTg0N2ItYThmYWFiOGE3YjRmLTExMDI3Njg=\/tiny\/Solid-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLESTOWN, Mass., April 21, 2023 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Solid management will participate in a fireside chat at Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 24, 2023 at 2:00 PM ET. A live webcast of the fireside chat will be available on the Events page of the Investors section of the Company website or by clicking here. A replay will be available on the Company\u2019s website following the event. Institutional investors interested in meeting with management during the conference may reach out to their Chardan representative. About Solid BiosciencesSolid Biosciences is a life science company &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749982","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLESTOWN, Mass., April 21, 2023 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Solid management will participate in a fireside chat at Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 24, 2023 at 2:00 PM ET. A live webcast of the fireside chat will be available on the Events page of the Investors section of the Company website or by clicking here. A replay will be available on the Company\u2019s website following the event. Institutional investors interested in meeting with management during the conference may reach out to their Chardan representative. About Solid BiosciencesSolid Biosciences is a life science company &hellip; Continue reading &quot;Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-21T12:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit\",\"datePublished\":\"2023-04-21T12:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/\",\"name\":\"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=\",\"datePublished\":\"2023-04-21T12:03:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Market Newsdesk","og_description":"CHARLESTOWN, Mass., April 21, 2023 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Solid management will participate in a fireside chat at Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 24, 2023 at 2:00 PM ET. A live webcast of the fireside chat will be available on the Events page of the Investors section of the Company website or by clicking here. A replay will be available on the Company\u2019s website following the event. Institutional investors interested in meeting with management during the conference may reach out to their Chardan representative. About Solid BiosciencesSolid Biosciences is a life science company &hellip; Continue reading \"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-21T12:03:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit","datePublished":"2023-04-21T12:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/","name":"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=","datePublished":"2023-04-21T12:03:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjI5NSM1NTM4NDE5IzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-to-participate-in-chardans-7th-annual-genetic-medicines-and-cell-therapy-manufacturing-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences to Participate in Chardan\u2019s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749982"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749982\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}